quality control

Sanofi

Pharma

Sanofi unit in Ireland dinged by FDA on Altuviiio production

After a site visit by FDA inspectors yielded a Form 483 for Genzyme in early 2026, the Sanofi unit is facing further scrutiny from the regulator.

Fraiser Kansteiner Jul 1, 2026 2:52pm

Person wearing a Lilly vest standing next to an Nvidia GPU

Fierce Biotech

Lilly debuts Nvidia supercomputer with fanfare and focus

Feb 27, 2026 1:37pm

Rise increase upward trajectory arrow ascent ascending

Teva debuts innovation platform to parry key industry challenges

Nov 19, 2025 8:38am

Novo Nordisk

Novo adds $112M quality testing lab to list of China investments

Jul 9, 2025 10:09am

inspection investigation FDA FDA inspection

FDA hits Piramal with 6-observation Form 483 at India API plant

Feb 26, 2025 10:22am

FDA

Sanofi hit with warning letter at Massachusetts ingredient plant

Jan 21, 2025 12:26pm